Statistics

Total Visits

Views
Bosutinib apears to be safe, with low cross intolerance, in patients treated in 4th line. Results of the Spanish compassionate use program47

Select a period of time:

Number of views in the range

Views
Bosutinib apears to be safe, with low cross intolerance, in patients treated in 4th line. Results of the Spanish compassionate use program20

Views

Views
May 20252
June 20250
July 202511
August 20251
September 20253
October 20252
November 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil8
Argentina3
Hong Kong2
United States2
United Kingdom2
Austria1
Colombia1
Italy1
 

Top cities views

Views
Hong Kong2
Barranquilla1
Campinas1
Campo Grande1
Canoinhas1
Cornélio Procópio1
Dallas1
Diamantina1
Duns1
Goiânia1